Numerous technological advancements have been integrated into proteomics array technologies. Enhanced surface chemistries combined with enlarged content menus are allowing manufacturers to develop ...

Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.

Explore how proteomics enhances infectious disease detection, pathogen identification, and host response profiling in ...

Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the ...

New nanoElute 2 features nano-LC advances, supports automated single cell sample preparation from label-free ProteoCHIP on CellenONE platform MetaboScape® 2023 advances fluxomics applications and ion ...

Proteomics, which is generally defined as the characterization of the complete protein complement of a cell, tissue, or organism (a proteome), has moved to the forefront of "big science" now that the ...

Tandem Mass Tag™ (TMT™) reagents enable simultaneous identification and relative quantification of thousands of proteins from many samples in a single LC-MS/MS acquisition on Thermo Scientific™ ...

Proteomics is the large-scale study of proteins, particularly their structures and functions. It involves the systematic identification, quantification, and analysis of the entire protein complement ...

SCHLIEREN, Switzerland and BILLERICA, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Biognosys AG and Bruker Corporation (Nasdaq: BRKR) today announced a strategic partnership, in which Bruker has made a ...

MAASTRICHT, Netherlands--(BUSINESS WIRE)--At the International Mass Spectrometry Conference (IMSC 2022), Bruker Corporation (Nasdaq: BRKR) today announced the launch of the new nanoElute® 2 nano-LC, ...

Host responses to SARS-CoV-2 are dynamic and complex. Here I will present applications of advanced proteomics technologies to interrogate host responses in the sera, urine and tissue specimens from ...